About our
Quality Policy

Our Quality Policy is focused on business continuity. For NimaGen, its employees, customers, and business partners. We are convinced that the ability of the NimaGen organisation to maintain essential functions can only be warranted when environmental protection and sustainability, good and safe working conditions, organizational learning, high quality standards, and organizational alignment are an integral part of the total enterprise. To support this, all aspects of the organisation's systems, processes and standards are combined into our Integrated Management System (IMS).

NimaGen is committed to increased performance, employee and customer satisfaction, and continuous improvement. The IMS coordinated, systemic effort allows us to streamline our process management, eliminate error, mitigate risks, and increase efficiency and effectiveness by addressing all elements of the management system as a whole, while minimizing the disruption caused by external audits. Our regularly maintained and frequently audited IMS is driven by the following guiding principles: Quality and Improvement.

NimaGen, part of the Dutch Biolegio Holding and founded in 2011, is a well-recognized manufacturer and provider of high-quality reagents for Sanger Sequencing and Fragment Analysis (Capillary Electrophoresis) and Next-generation Sequencing (NGS), used by molecular biology laboratories around the world.

The ability of these laboratories to provide consistent and reliable results to their customers depends on the consistent supply of high-quality reagents over time. Evaluating NimaGen manufacturing capability requires an understanding of how we manage and control our manufacturing operations to ensure your product is delivered on time and to your specifications every time. 

We believe our reagent products and services must meet your expectations and, even better, should surpass these expectations. To achieve this goal, our integrated R&D, production, quality control, sales and customer service process is monitored and controlled under recognized ISO 9000 and ISO 13485 quality management system certification. NimaGen sites and departments engage in continuous improvement of these quality programs.

We believe that building a high level of quality and customer satisfaction is based on a collaborative approach, pivotal in warranting a continued flow of improved and novel products and associated services to the laboratory science community. Feedback from both you and our staff on this subject is very much appreciated.

Each business year, our management team will determine concrete, measurable key performance indicators (KPIs) relative to the expectations of both our customers and staff, as well as other business objectives. Performance and progress are monitored and frequently evaluated against these pre-determined KPIs, to assess how effectively business objectives are met, or may require appropriate and effective follow-up. 

NimaGen strives to excel in all its undertakings, our IMS set up to meet the highest requirements for audit and certification of quality management. While complying with all relevant regulatory, legal, business and contractual security obligations, we will ensure that any risks, threats and vulnerabilities associated with our business are adequately identified, assessed and mitigated. Similarly, we will identify and embrace any opportunity that would be beneficial to our company and our valued customers.
 

Ruud van der Steen                    
CEO NimaGen